Clinical Trial Update: Akyva First In Human [NA]

View source ↗

Summary

This update notes the first-in-human study of Akyva by Iota Biosciences for underactive bladder, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Underactive Bladder

Drugs mentioned

• Akyva

Snippet

Sponsor: Iota Biosciences, Inc | Conditions: Underactive Bladder | NA | Status: RECRUITING